Home > Analytics > AAREY DRUGS & PHARMACEUTICALS

AAREY DRUGS & PHARMACEUTICALS
Intrinsic Value | Fundamental Analysis

BOM : 524412     NSE : AAREYDRUGS    
LT :  
    Long Term Analysis
Fundamentals : Bad
Valuation : Bad [Stock is Expensive]
Debt : Low
Updated:
ST :  
    Short Term Analysis
Quarterly Earnings Trend : Downward
Price Momentum : Upward
Pledged Shares : None or < 25%
Oct 19,2026
Price(EOD): ₹ 113.35
This is the End-of-Day (EOD) Stock Price updated daily by 7 pm IST.
Trading
MCap: ₹ 361.59 Cr
Value of ₹ 1 Lac invested in AAREY DRUGS & PHARMACEUTICALS
on Oct 19,2021 (price: ₹ 35.35)

₹ 1 L

→

₹ 3.21 L

1W : 9.9% 1M : 11.9% 1Y : 39.9%
COMMUNITY POLL
for AAREY DRUGS & PHARMACEUTICALS
Please provide your vote to see the results
AAREY DRUGS & PHARMACEUTICALS is part of below Screeners ↓
Best 1M Momentum Small Cap Stocks
Industry Peers & Returns1W1M1Y
AAREY DRUGS & PHARMACEUTICALS 9.9% 11.9% 39.9%
ADANI ENTERPRISES -1.4% -9.2% 9.7%
PREMIER ENERGIES -0.1% 1.8% -12.5%
ADITYA INFOTECH -8.2% 18.8% 197.8%
AEGIS LOGISTICS -4.3% -1.5% 68.6%
REDINGTON -5.4% -7.3% 37.5%
RRP SEMICONDUCTOR -3.9% -19% 4545.9%
HONASA CONSUMER -5.4% -4.1% 59.7%
LLOYDS ENTERPRISES -3.3% 2.4% 2.7%

FUNDAMENTAL ANALYSIS OF AAREY DRUGS & PHARMACEUTICALS

 
Fundamentals Score
[ Q(TTM): Jun2026, Y: Mar2026
Q : Last Qtr data
Y : Last Audited Annual/Yearly Data
TTM i.e. Trailing Twelve Months is calculated using last 4 quarterly data and is a good substitute to track last 4 Qtr Annual result before the subsequent year data is published and audited.
Learn More
]



VALUATION OF AAREY DRUGS & PHARMACEUTICALS

 
Valuation Score
[As on : Oct 19,2026 ]

Ratio Standalone
P/E
P/B
P/S
86.52
P/E Calculated based on Trailing Twelve Months (TTM) Earnings of Rs 4.18 Cr
[Latest Qtr - Jun2026 - Standalone Results ]

2.46
P/B Calculated based on Book Value of Rs 146.66 Cr
[Latest Year - Mar2026 - Standalone Results ]

0.87
P/S Calculated based on Trailing Twelve Months (TTM) Revenues of Rs 0.00 Cr
[Latest Qtr - Jun2026 - Standalone Results ]

Financial Ratios →

Insights 💡 There are potential 73% undervalued companies ! Discover More →

FAIR VALUE OF AAREY DRUGS & PHARMACEUTICALS

 
Model Discount(-)/
Premium(+)
EV/EBIDTA
EV/Sales
Price/Sales
NA
492%
397%

Insights 💡 You can learn about various Valuation techniques to calculate Intrinsic Value
with our bestselling video course Value Investing - The Ultimate Guide
Take Me There →

SHARE PRICE MOMENTUM OF AAREY DRUGS & PHARMACEUTICALS


Insights 💡 AAREYDRUGS is one of the top 45% companies with bullish price momentum currently! Discover More →

AAREY DRUGS & PHARMACEUTICALS vs SENSEX


Insights 💡 You can learn about Basics of Stock Marketing Investing
with our bestselling video course Stock Marketing Investing Simplified
Take Me There →

DEBT OF AAREY DRUGS & PHARMACEUTICALS

Year Debt/Equity ratio
Standalone Consolidated
2026
2025
2024
Avg_3yrs
0.34
0.26
0.24
0.28
-
-
-
-
[Last Annual Data : Mar2026]
Financial Ratios →

PLEDGED PROMOTER SHARES OF AAREY DRUGS & PHARMACEUTICALS

Pledged Promoter Shares
0 %
As on : Jun2026

If less than 25%

Good
If between 25% and 50% Neutral
If greater than 50% Bad
Shareholding Pattern →

QTRLY RESULTS OF AAREY DRUGS & PHARMACEUTICALS

Standalone Q-o-Q Y-o-Y
Revenue
Op Profit
Profit Before Tax
Profit After Tax
-76.45%
-69.45%
-59.69%
-34.23%
-56.34%
-22.09%
-70.14%
-25.31%
QtrlyTrend
-8
Latest Qtr: Jun2026
Quarterly Result Analysis →


AAREY DRUGS & PHARMACEUTICALS related INDICES

No BSE index found!
No NSE index found

You may also like the below Video Courses


FAQ about AAREY DRUGS & PHARMACEUTICALS


Is AAREY DRUGS & PHARMACEUTICALS good for long term investment?

As on Oct 19,2026, the Fundamentals of AAREY DRUGS & PHARMACEUTICALS look Poor and hence it may not be good for long term investment ! See Financial Performance of AAREY DRUGS & PHARMACEUTICALS . Please look at the other parameters such as Valuation, Price Momentum, News & Corporate Governance and/or consult an Investment Advisor before taking an investment decision!

Is AAREY DRUGS & PHARMACEUTICALS UnderValued or OverValued?

As on Oct 19,2026, AAREY DRUGS & PHARMACEUTICALS is Over Valued based on the estimates of intrinsic value and hence may not be a good buying opportunity according to Share Valuation at this time!

What is the Intrinsic Value of AAREY DRUGS & PHARMACEUTICALS ?

As on Oct 19,2026, the Intrinsic Value of AAREY DRUGS & PHARMACEUTICALS is Rs. 20.97 estimated based on Median of the 3 historical models.
Fair Value [Median EV / EBIDTA Model] : Rs. -2.57
Fair Value [Median EV / Sales Model] : Rs. 19.14
Fair Value [Median Price / Sales Model] : Rs. 22.80
Estimated Median Fair Value of AAREY DRUGS & PHARMACEUTICALS : Rs. 20.97

The fair value of any stock is always subjective and should, in no way, be taken as a recommendation to buy/sell the same.

Is AAREY DRUGS & PHARMACEUTICALS trading at a Premium or Discount?

As on Oct 19,2026, AAREY DRUGS & PHARMACEUTICALS is trading at a Premium of 441% based on the estimates of Median Intrinsic Value!